lucia gabriele
National Institute of Health (ISS)
Rome, Italy
Associate Editor
Cancer Immunity and Immunotherapy
Editors
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
christian gaiddon
U1113, IRFAC, Interface of Research Foundamental and Applied in Cancer
Strasbourg, France
Associate Editor
Cancer Immunity and Immunotherapy
udo s gaipl
University Hospital Erlangen
Erlangen, Germany
Associate Editor
Cancer Immunity and Immunotherapy
domenico galati
Haematology-Oncology and Stem Cell Transplantation Unit, Department of Haematology and Innovative Diagnostics, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale
Napoli, Italy
Associate Editor
Cancer Immunity and Immunotherapy
francesco galimi
Adicet Bio, Inc
Menlo Park, United States
Associate Editor
Cancer Immunity and Immunotherapy
christine galustian
King's College London
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
sofia r gameiro
National Cancer Institute (NIH)
Rockville, United States
Associate Editor
Cancer Immunity and Immunotherapy
jose a. garcia-sanz
Spanish National Research Council (CSIC)
Madrid, Spain
Associate Editor
Cancer Immunity and Immunotherapy
abhishek d garg
KU Leuven
Leuven, Belgium
Associate Editor
Cancer Immunity and Immunotherapy
prof dr martin gasser
Julius Maximilian University of Würzburg
Würzburg, Germany
Associate Editor
Cancer Immunity and Immunotherapy
luca gattinoni
Leibniz Institute for Immunotherapy (LIT)
Regensburg, Germany
Associate Editor
Cancer Immunity and Immunotherapy
alessandra gentilini
University of Florence
Florence, Italy
Associate Editor
Cancer Immunity and Immunotherapy
abbas ghaderi
Shiraz University of Medical Sciences
Shiraz, Iran
Associate Editor
Cancer Immunity and Immunotherapy
francois ghiringhelli
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
ehsan ghorani
Imperial College London
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
nicolas a giraldo
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Immunity and Immunotherapy